Is Copper the new Gold??! Co-PSMA trial in European Urology

Now this is an interesting one, a new PSMA tracer which appears to greatly outperform 68Ga-PSMA-11 for biochemical recurrence. We discuss 64Cu-SAR-bisPSMA with Professor Louise Emmett (Nuclear Medicine Physician, Sydney), and Dr Matt Roberts (Urologist, Brisbane), which they compared head to head with trusty old 68Ga-PSMA-11 in the Co-PSMA trial, just published in European Urology.

With usual hosts Declan Murphy and Renu Eapen. This Themed Podcast is supported by our new Bronze Partners, Clarity Pharmaceuticals

Also available as an audio podcast - just search GU Cast wherever you get yours

Links:

Co-PSMA trial in European Urology

Clarity Pharmaceuticals

 

Also available as an audio podcast, just search Gu Cast, or listen directly below

Previous
Previous

ARASEC and Lead-in ADT - China focus

Next
Next

EAU Prostate Cancer Guideline Update